RxDoctor Payments Data

Kimberly Cushing

Family · Worcester, MANPI 1477266732

Payments from drug & device makers

$218in general payments, 2019–2025

Across 7 payments — averaging $31.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$99
  • Biogen$44
  • Eisai Inc.$37
  • Argenx US, Inc.$21
  • AbbVie$16

What the payments were for

  • Food & beverage$218100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen1$99
Biogen2$44
Eisai Inc.2$37
Argenx US, Inc.1$21
AbbVie1$16

How this compares

$218 in reported general payments places this provider in the 55th percentile of 2,320 family providers in Massachusetts.

See all family providers in Massachusetts

Medicare billing

Part B allowed, 2024
$2,831,074
Medicare patients
278
Services billed
201,595

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Worcester

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →